http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109846872-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 |
| filingDate | 2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109846872-B |
| titleOfInvention | Medicine and functional food for preventing and treating posttraumatic stress syndrome |
| abstract | The invention discloses a medicine or functional food for preventing or/and treating post-traumatic stress syndrome, which consists of S-methyl-L-cysteine (sulphur methyl L-cysteine) or amino acid salt of sulphur methyl L-cysteine and pharmaceutically or food industry acceptable additives or/and carriers, wherein the S-methyl-L-cysteine can be provided by plant extracts which are rich in S-methyl-L-cysteine and used as raw materials. The medicine or functional food of the invention can generate the dissipation promotion effect on the fear memory related to the traumatic stress by reducing the in vivo oxidative stress level, reducing free radicals, enhancing the synaptic plasticity dependent on NMDA receptors in related brain areas and the like, thereby treating the behavior abnormality caused by the post-traumatic stress. |
| priorityDate | 2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.